NoteData shown are approximate and may vary depending on individual factors and the different chemotherapy regimens used, such as Cyclophosphamide, Daunorubicin, Docetaxel (Taxotere), Doxorubicin, Paclitaxel (Taxol) and others. For more detailed and specific information on the effectiveness of scalp cooling with different drugs, please refer to specialised studies.
As the management of the side effects of chemotherapy becomes a priority in the field of oncology, research into treatments such as scalp cooling and cryocompression for chemotherapy-induced peripheral neuropathy has become essential.
In this section, you will find a variety of articles exploring the latest developments and leading research on the use of cryogenic caps.
These studies and publications provide detailed and up-to-date information on the efficacy, applications and benefits of this innovative technique to mitigate hair loss and other side effects during chemotherapy treatment.
Estimated hair loss without scalp cooling (without cap):
That is, out of every 100 patients on your type of chemotherapy, approximately XX% experience significant hair loss.
Estimation of hair loss with scalp cooling (with cap):
That is, out of every 100 patients using scalp cooling, hair is retained in a remarkable XX% of cases.
This data has been analysed and compiled from several dozen scientific studies and articles published in prestigious journals. Using state-of-the-art artificial intelligence, the results have been processed and combined to provide an accurate and up-to-date picture of the likelihood of hair loss in chemotherapy treatments.
The use of cooling caps may not be appropriate for certain types of cancer or chemotherapy treatments, such as leukaemias and lymphomas. In patients with metastases to the scalp or any area of the head (including the skull and meninges), the decision on the use of cooling should be assessed on an individual basis and always under the supervision of a specialised medical team.
Here you will find published scientific studies, carefully analysed, translated and interpreted using artificial intelligence to facilitate their understanding and application in the management of the side effects of chemotherapy.
The United States Food and Drug Administration (FDA) has approved the expanded use of a cooling system, known as scalp
Choosing a scalp cooling cap during chemotherapy is a decision that impacts the physical and emotional well-being of those going to chemotherapy.
Hair loss is one of the most visible and emotional side effects of chemotherapy, and it can deeply affect the
A cooling cap is a specially designed device that is placed on the scalp to keep it cold during chemotherapy.
Scalp cooling caps have become a useful tool for reducing hair loss during chemotherapy. However, there are specific situations where
Introduction: Scalp cooling is the only available method to prevent chemotherapy-induced alopecia (CIA). While its effectiveness varies, being satisfactory in
Introduction This article addresses one of the most distressing side effects of chemotherapy: induced alopecia. Hair loss has a considerable
Introduction Chemotherapy-induced alopecia (CIA) is a common and emotionally distressing side effect for patients with early-stage breast cancer. Scalp cooling
Introduction Chemotherapy-induced alopecia (CIA) is one of the most common and distressing side effects of breast cancer treatment. Hair loss,
Introduction Chemotherapy-induced alopecia is a side effect that can have a significant emotional impact on cancer patients. Hair loss, although
Introduction The study «Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Receiving Chemotherapy: A Prospective Multicenter Study of
Document Analysis Method: In today's digital era, artificial intelligence (AI) has transformed the way we process and understand information. Using
Introduction: The gel scalp cooling cap is a tool used to prevent hair loss in patients receiving chemotherapy treatment. This
The 1980 scalp cooling cap patent introduced an innovative solution to reduce alopecia in patients undergoing chemotherapy. This cap uses cooling technology to decrease blood flow to hair follicles during treatment, thereby minimizing hair loss. Its anatomical design and high-quality materials ensure comfort and effectiveness, improving patients’ quality of life and emotional well-being.
Preserving hair during chemotherapy is much more than an aesthetic matter: it's about protecting self-esteem, maintaining identity, and offering crucial
The Princess of Wales, Kate Middleton, visited the Royal Marsden Hospital in London, where she received cancer treatment in 2024.
Scalp cooling caps are an effective tool for reducing hair loss during chemotherapy treatments. Below, we present a detailed guide
Introduction Scalp cooling has been used since the 1970s to mitigate chemotherapy-induced alopecia (CIA), a common and emotionally challenging side effect of chemotherapy.
Preserving hair during chemotherapy is much more than a matter of aesthetics: it is about protecting self-esteem, maintaining one's identity
The U.S. Food and Drug Administration (FDA) has approved the extension of
